Approvals/CIMA-AEMPS/COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/5 MICROGRAMOS)/DOSIS CONCENTRADO PARA DISPERSION INYECTABLE

Approved

STANDARD

COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/5 MICROGRAMOS)/DOSIS CONCENTRADO PARA DISPERSION INYECTABLE

Biontech Manufacturing Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6e34b76433b54cfe
Drug Cima Aemps Name: COMIRNATY ORIGINAL/OMICRON BA.4-5 (5/5 MICROGRAMOS)/DOSIS CONCENTRADO PARA DISPERSION INYECTABLE
Register Number: 1201528011
Holder Company Name: Biontech Manufacturing Gmbh
Marketing Company Name: Pfizer S.L.
Holder Company Detail Path: /organization/biontech-manufacturing-gmbh
Authorization Date: 2022-11-17
Dosage Form: CONCENTRADO PARA DISPERSION INYECTABLE
Dose: 0,2 ML
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Biontech Manufacturing Gmbh
Company Detail Path: /organization/biontech-manufacturing-gmbh

TOZINAMERAN

0,05 mg/ml

FAMTOZINAMERAN

0,05 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 17, 2022

Approval ID

6e34b76433b54cfe

Type

Standard